Qingsheng (Ching) Zhu

Dr. Zhu is a Managing Partner of Frontline BioVentures (www.frontlinebioventures.com) and in charge of its medtech investment practice. He has over 20 years of experience in the medical device Industry as a researcher,product developer, a serial entrepreneur and a venture capitalist. His past positions include a partner with Novitas Capital, an early stage venture firm based in Pennsylvania and Founder/CEO of Action Medical, a venture funded device company developing novel stimulation therapies to treat heart failure.

Action Medical was acquired by Boston Scientific in 2009. Dr. Zhu spent 10 years at Guidant Corporation (now part of Boston Scientific) and produced over 200 US patents there. Dr. Zhu was selected by the China Central HR as a Thousand Talent Expert in 2011. Currently, he serves on the Board of a number of portfolio companies including JC Medical, MidLabs, Realton, and Micor.